reference/33824503

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33824503

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1530-9932
issueIdentifier	6
pageRange	202-
publicationName	AAPS PharmSciTech
startingPage	202
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8302ff0a55ff5deaaeeae881f905205c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c552d0a3e0057ff5996e6e25f1cf6f8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36b8bba3e5bca5b3ff5cc1c47f0eb6bc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e721e02d016e6113c317061b937dd964 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation	Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment. AAPS PharmSciTech. 2020 Jul 21;21(6):202. PMID: 32696338; PMCID: PMC7995642.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_784e5cd4da882a13447a1dcde6868a3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9be079e158acd5167422706c6d5b4be6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3956-1003 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d877b12c4a74d35b66fb0fcf6eb2e218 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7f972fcbbdf59c2687cbcfb0f82aa5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ff4dc64a764589e27a6a2a408d4add3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_960bfa37442ae176cd1bc762f6e1e062 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c80b043c1c22acfd553a589289523643
date	2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32696338 https://doi.org/10.1208/s12249-020-01743-8 https://pubmed.ncbi.nlm.nih.gov/PMC7995642
isPartOf	https://portal.issn.org/resource/ISSN/1530-9932 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30088
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment
discusses	http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M0417713 http://id.nlm.nih.gov/mesh/M0017182 http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0012600 http://id.nlm.nih.gov/mesh/M0028048
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160339 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10350317 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d97d0b206f496732550c6f379834bf98 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497103 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6987d73c53561e4c4cd9227dbdb5ffa2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Total number of triples: 50.